723
Views
23
CrossRef citations to date
0
Altmetric
Review

Management of nocturnal hypertension

&
Pages 607-618 | Published online: 10 Jan 2014

References

  • Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N. Engl. J. Med.354(22), 2368–2374 (2006).
  • Pickering TG, James GD. Determinants and consequences of the diurnal rhythm of blood pressure. Am. J. Hypertens.6(6 Pt 2), S166–S169 (1993).
  • James GD, Pickering TG. The influence of behavioral factors on the daily variation of blood pressure. Am. J. Hypertens.6(6 Pt 2), S170–S173 (1993).
  • Peixoto AJ, White WB. Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Curr. Opin. Nephrol. Hypertens.11(5), 507–516 (2002).
  • Brotman DJ, Davidson MB, Boumitri M, Vidt DG. Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens.21(1), 92–97 (2008).
  • Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML, Deedwania PC, Willerson JT. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events participants. Circulation96(9), 3233–3239 (1997).
  • Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation107(10), 1401–1406 (2003).
  • Ishikawa J, Shimizu M, Hoshide S et al. Cardiovascular risks of dipping status and chronic kidney disease in elderly Japanese hypertensive patients. J. Clin. Hypertens. (Greenwich)10(10), 787–794 (2008).
  • Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension16(6), 692–699 (1990).
  • Redon J, Lurbe E. Nocturnal blood pressure versus nondipping pattern: what do they mean?. Hypertension51(1), 41–42 (2008).
  • Peixoto AJ, White WB. Circadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int.71(9), 855–860 (2007).
  • Nielsen FS, Hansen HP, Jacobsen P et al. Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy. Diabet. Med.16(7), 555–562 (1999).
  • Grassi G, Seravalle G, Quarti-Trevano F et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension52(5), 925–931 (2008).
  • Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am. J. Hypertens.12(1 Pt 1), 63–68 (1999).
  • Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension30(5), 1062–1067 (1997).
  • Portaluppi F, Bagni B, degli Uberti E et al. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J. Hypertens.8(1), 85–95 (1990).
  • Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension48(4), 527–533 (2006).
  • Fujii T, Uzu T, Nishimura M et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am. J. Kidney Dis.33(1), 29–35 (1999).
  • Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension51(4), 891–898 (2008).
  • Saifur Rohman M, Emoto N, Nonaka H et al. Circadian clock genes directly regulate expression of the Na+/H+ exchanger NHE3 in the kidney. Kidney Int.67(4), 1410–1419 (2005).
  • White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press. Monit.5(Suppl. 1), S17–S23 (2000).
  • Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease – from mice and man. Pharmaco. Ther.111(3), 629–651 (2006).
  • Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev.59(9–10), 923–939 (2007).
  • Pogue V, Rahman M, Lipkowitz M et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension53(1), 20–27 (2009).
  • Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol. Dial. Transplant.12(11), 2301–2307 (1997).
  • Peixoto AJ, Sica DA. Ambulatory blood pressure monitoring in end-stage renal disease. Blood Press. Monit.2(6), 275–282 (1997).
  • Tamura K, Yamauchi J, Tsurumi-Ikeya Y et al. Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy. Clin. Exp. Hypertens.30(1), 33–43 (2008).
  • Tartan Z, Uyarel H, Kasikcioglu H et al. Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J. Exp. Med.210(1), 57–66 (2006).
  • Vyssoulis G, Karpanou E, Adamopoulos D et al. Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension. Blood Press. Monit.13(5), 251–256 (2008).
  • Okamoto LE, Gamboa A, Shibao C et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension53(2), 363–369 (2009).
  • Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C. 24-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J. Hypertens.16(10), 1433–1441 (1998).
  • Cardoso CR, Leite NC, Freitas L, Dias SB, Muxfeld ES, Salles GF. Pattern of 24-hour ambulatory blood pressure monitoring in Type 2 diabetic patients with cardiovascular dysautonomy. Hypertens. Res.31(5), 865–872 (2008).
  • Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep31(6), 795–800 (2008).
  • Matthews KA, Kamarck TW, Hall M et al. Blood pressure dipping and sleep disturbance in African–American and Caucasian men and women. Am. J. Hypertens.21(7), 826–831 (2008).
  • Bouhanick B, Chamontin B. Should pulse pressure and day–night variations in blood pressure be seen as independent risk factors requiring correction or simply as markers to be taken into account when evaluating overall vascular risk?. Diabetes Metab.33(5), 321–330 (2007).
  • Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension49(6), 1235–1241 (2007).
  • Boggia J, Li Y, Thijs L et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet370(9594), 1219–1229 (2007).
  • Staessen JA, Thijs L, Fagard R et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA282(6), 539–546 (1999).
  • Eguchi K, Ishikawa J, Hoshide S et al. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with Type 2 diabetes. Am. J. Hypertens.22(1), 46–51 (2009).
  • Ohkubo T, Hozawa A, Yamaguchi J et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens.20(11), 2183–2189 (2002).
  • Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab.34(6 Pt 1), 560–567 (2008).
  • Amar J, Vernier I, Rossignol E et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int.57(6), 2485–2491 (2000).
  • Hoshide S, Kario K, Hoshide Y et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens.16(6), 434–438 (2003).
  • Ijiri H, Kohno I, Yin D et al. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension. Jpn Circ. J.64(7), 499–504 (2000).
  • Cuspidi C, Michev I, Meani S et al. Non-dipper treated hypertensive patients do not have increased cardiac structural alterations. Cardiovasc. Ultrasound1, 1 (2003).
  • Timio M, Venanzi S, Lolli S et al. “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin. Nephrol.43(6), 382–387 (1995).
  • Lurbe E, Redon J, Kesani A et al. Increase in nocturnal blood pressure and progression to microalbuminuria in Type 1 diabetes. N. Engl. J. Med.347(11), 797–805 (2002).
  • Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch. Intern. Med.166(8), 846–852 (2006).
  • Farmer CK, Goldsmith DJ, Quin JD et al. Progression of diabetic nephropathy – is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrol. Dial. Transplant.13(3), 635–639 (1998).
  • Metoki H, Ohkubo T, Kikuya M et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension47(2), 149–154 (2006).
  • Peixoto AJ, Santos SF, Mendes RB et al. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am. J. Kidney Dis.36(5), 983–990 (2000).
  • Omboni S, Parati G, Palatini P et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J. Hypertens.16(6), 733–738 (1998).
  • Hermida RC, Calvo C, Ayala DE, Lopez JE. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension46(4), 960–968 (2005).
  • Black HR, Elliott WJ, Grandits G et al. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region. J. Hypertens.23(5), 1099–1106 (2005).
  • Hermida RC. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int.24(4), 749–775 (2007).
  • Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation96(6), 1859–1862 (1997).
  • Uzu T, Kimura G, Yamauchi A et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J. Hypertens.24(8), 1627–1632 (2006).
  • Takakuwa H, Shimizu K, Izumiya Y et al. Dietary sodium restriction restores nocturnal reduction of blood pressure in patients with primary aldosteronism. Hypertens. Res.25(5), 737–742 (2002).
  • Uzu T, Nishimura M, Fujii T et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J. Hypertens.16(12 Pt 1), 1745–1748 (1998).
  • Wilson DK, Sica DA, Devens M, Nicholson SC. The influence of potassium intake on dipper and nondipper blood pressure status in an African–American adolescent population. Blood Press. Monit.1(6), 447–455 (1996).
  • Svetkey LP, Yarger WE, Feussner JR, DeLong E, Klotman PE. Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension9(5), 444–450 (1987).
  • Gu D, He J, Wu X, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J. Hypertens.19(7), 1325–1331 (2001).
  • Whelton PK, He J, Cutler JA et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA277(20), 1624–1632 (1997).
  • Morillo MG, Amato MC, Cendon Filha SP. Twenty-four hour blood pressure record for smokers and nonsmokers. Arq. Bras. Cardiol.87(4), 504–511 (2006).
  • Oncken CA, White WB, Cooney JL, Van Kirk JR, Ahluwalia JS, Giacco S. Impact of smoking cessation on ambulatory blood pressure and heart rate in postmenopausal women. Am. J. Hypertens.14(9 Pt 1), 942–949 (2001).
  • Ohira T, Tanigawa T, Tabata M et al. Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension53(1), 13–19 (2009).
  • Aguilera MT, de la Sierra A, Coca A, Estruch R, Fernandez-Sola J, Urbano-Marquez A. Effect of alcohol abstinence on blood pressure: assessment by 24-hour ambulatory blood pressure monitoring. Hypertension33(2), 653–657 (1999).
  • Yilmaz MB, Yalta K, Turgut OO et al. Sleep quality among relatively younger patients with initial diagnosis of hypertension: dippers versus non-dippers. Blood Press.16(2), 101–105 (2007).
  • Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, Martinez TG, Bernacer-Alpera B, Roman-Sanchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur. Respir. J.29(5), 951–957 (2007).
  • Norman D, Loredo JS, Nelesen RA et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension47(5), 840–845 (2006).
  • Bannister R, Ardill L, Fentem P. An assessment of various methods of treatment of idiopathic orthostatic hypotension. Q. J. Med.38(152), 377–395 (1969).
  • Hermida RC, Smolensky MH. Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens.13(5), 501–505 (2004).
  • Hermida RC, Ayala DE, Calvo C. Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens.14(5), 453–459 (2005).
  • White WB, Sica DA, Calhoun D, Mansoor GA, Anders RJ. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. Am. Heart J.144(4), 657–665 (2002).
  • Hermida RC, Ayala DE, Fernandez JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension51(1), 69–76 (2008).
  • Minutolo R, Gabbai FB, Borrelli S et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am. J. Kidney Dis.50(6), 908–917 (2007).
  • Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am. J. Hypertens.8(7), 719–726 (1995).
  • Hermida RC, Calvo C, Ayala DE et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J. Hypertens.23(10), 1913–1922 (2005).
  • Hermida RC, Ayala DE, Calvo C et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension46(4), 1060–1068 (2005).
  • Uzue T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation100(15), 1635–1638 (1999).
  • White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. Am. Heart J.148(4), 628–634 (2004).
  • Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension50(4), 715–722 (2007).
  • Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int.26(1), 61–79 (2009).
  • Oh BH, Mitchell J, Herron JR, Chung J, Khan M, Keefe DL. Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension. J. Am. Coll. Cardiol.49(11), 1157–1163 (2007).
  • White WB, Mansoor GA, Pickering TG et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am. J. Hypertens.12(8 Pt 1), 806–814 (1999).
  • Hermida RC, Ayala DE, Mojon A, Fernandez JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am. J. Hypertens.21(8), 948–954 (2008).
  • Hermida RC, Ayala DE, Mojon A et al. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol. Int.25(6), 950–970 (2008).
  • Ernst ME, Carter BL, Goerdt CJ et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension47(3), 352–358 (2006).
  • Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med.161(5), 1423–1428 (2000).
  • Hermida RC, Calvo C, Ayala DE. Administration time-dependent effects of nebivolol on ambulatory blood pressure in patients with essential hypertension. Am. J. Hypertens.18, 62–63 (2005).
  • Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of a-adrenergic blocker, doxazosin: results from the HALT study. Hypertension35(3), 787–794 (2000).
  • Hermida RC, Calvo C, Ayala DE et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int.21(2), 277–296 (2004).
  • Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J. Pineal Res.42(4), 319–322 (2007).
  • Grossman E, Laudon M, Yalcin R et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am. J. Med.119(10), 898–902 (2006).
  • Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am. J. Hypertens.18(12 Pt 1), 1614–1618 (2005).
  • Bakris GL, Ruilope LM, McMorn SO et al. Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in Type 2 diabetes patients with microalbuminuria. J. Hypertens.24(10), 2047–2055 (2006).
  • Negro R, Dazzi D, Hassan H, Pezzarossa A. Pioglitazone reduces blood pressure in non-dipping diabetic patients. Minerva Endocrinol.29(1), 11–17 (2004).
  • Hermida RC, Ayala DE, Calvo C et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension46(4), 1053–1059 (2005).
  • Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension50(2), 417–423 (2007).
  • Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch. Intern. Med.167(8), 757–764 (2007).
  • Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, Lima-Alvarez J, Benitez MA, Almeida-Gonzalez C. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest132(6), 1847–1852 (2007).
  • Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am. J. Hypertens.11(3 Pt 1), 272–279 (1998).
  • Salo TM, Kantola I, Voipio-Pulkki LM, Pelttari L, Viikari JS. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients – assessment by spectral analysis of heart rate and blood pressure variability. Eur. J. Clin. Pharmacol.55(3), 191–198 (1999).
  • Shibao C, Gamboa A, Abraham R et al. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension47(3), 522–526 (2006).
  • Jordan J, Shannon JR, Pohar B et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J. Am. Soc. Nephrol.10(1), 35–42 (1999).
  • Kario K, Shimada K, Pickering TG. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J. Cardiovasc. Pharmacol.41(Suppl. 1), S61–S66 (2003).
  • Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J. Hypertens.10(8), 875–878 (1992).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.